These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7792204)

  • 1. Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma.
    Lucin K; Iternicka Z; Jonjić N
    Pathol Res Pract; 1994 Dec; 190(12):1134-40. PubMed ID: 7792204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.
    Oldford SA; Robb JD; Watson PH; Drover S
    Int J Cancer; 2004 Nov; 112(3):399-406. PubMed ID: 15382064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.
    Feinmesser M; Sulkes A; Morgenstern S; Sulkes J; Stern S; Okon E
    J Clin Pathol; 2000 Apr; 53(4):286-91. PubMed ID: 10823125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases.
    Lazzaro B; Anderson AE; Kajdacsy-Balla A; Hessner MJ
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):234-41. PubMed ID: 11556751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
    Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
    Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
    Georgiannos SN; Renaut A; Goode AW; Sheaff M
    Surgery; 2003 Nov; 134(5):827-34. PubMed ID: 14639362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of HLA class I antigens in breast cancer: association with prognosis.
    Gudmundsdóttir I; Gunnlaugur Jónasson J; Sigurdsson H; Olafsdóttir K; Tryggvadóttir L; Ogmundsdóttir HM
    Int J Cancer; 2000 Nov; 89(6):500-5. PubMed ID: 11102894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
    Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
    Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gains and losses of HLA class II (DR) and CD4 in atypical hyperplasia, carcinoma in situ and infiltrating ductal carcinoma of the breast.
    Tamiolakisl D; Venizelos I; Lambropoulou M; Jivannakis T; Seliniotakis E; Tsikouras P; Limberis V; Tsalkidis A; Papadopoulos N
    Acta Medica (Hradec Kralove); 2004; 47(4):257-62. PubMed ID: 15844251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of beta-1 integrins on tumor cells of invasive ductal breast carcinoma.
    Jonjić N; Lucin K; Krstulja M; Iternicka Z; Mustać E
    Pathol Res Pract; 1993 Nov; 189(9):979-84. PubMed ID: 7508107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
    Wintzer HO; Benzing M; von Kleist S
    Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
    Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
    Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.
    Zuk JA; Walker RA
    J Pathol; 1987 Aug; 152(4):275-85. PubMed ID: 3312546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas.
    Pupa SM; Bufalino R; Invernizzi AM; Andreola S; Rilke F; Lombardi L; Colnaghi MI; Ménard S
    J Clin Oncol; 1996 Jan; 14(1):85-94. PubMed ID: 8558226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
    Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
    J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of HLA-D/Ii antigen expression in breast carcinoma with local lymphohistiocytic infiltration reveals considerable dysregulation in a subset of tumors.
    Koretz K; Moldenhauer G; Majdic O; Möller P
    Int J Cancer; 1989 Nov; 44(5):816-22. PubMed ID: 2583862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes.
    Matsushita N; Ghazizadeh M; Konishi H; Araki T
    J Nippon Med Sch; 2003 Feb; 70(1):40-4. PubMed ID: 12646975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
    Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
    Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
    Bhan AK; DesMarais CL
    J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer.
    Sheen-Chen SM; Chou FF; Eng HL; Chen WJ
    Surgery; 1994 Sep; 116(3):510-5. PubMed ID: 8079182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.